Judge Issues $572 Million Verdict Against J & J in Oklahoma Opioids Trial: Settlements to Follow?
Judge issues $572 million verdict in J&J opioids trial. Some settlements of multiple pending lawsuits will likely follow.
Read more...Judge issues $572 million verdict in J&J opioids trial. Some settlements of multiple pending lawsuits will likely follow.
Read more...Hedge fund Chatham is might upset about a phrase we picked up from a New York Post article on Chatham funds’ investment, including a CalPERS fund, in the parent of the notorious National Enquirer.
Read more...A rabies ripoff.
Read more...What city will be next to admit it has a lead problem? Why yours might be closer than you think.
Read more...The World Bank wants to double down on financial gimmickry rather than develop the public health infrastructure to combat pandemics.
Read more...A Medicare lawsuit winding its way through the courts should take some of the wind out of the sails of the idea of Medicare in its current form as a good way to implement single payer.
Read more...New York City has set out to protect people — and the planet — from heat.
Read more...One way China could mess with the US.
Read more...Pondering the challenges of being old now.
Read more...A PR campaign presenting the consumer fraud known as surprise billing as beneficial doesn’t stand up to scrutiny.
Read more...How private equity ginned up yet another abuse.
Read more...A Trump proposal to force some price transparency on hospitals has them hopping mad.
Read more...Sanders puts the hot lights on the disgrace of insulin prices in the US.
Read more...Yet another reason to combat carbon emissions: More of them = less healthy food.
Read more...How rising temperatures helped create superbug C. auris and may turn other fungi lethal.
Read more...